Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning
Open Access
- 25 October 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-20
Abstract
This study aimed at establishing more accurate predictive models based on novel machine learning algorithms, with the overarching goal of providing clinicians with effective decision-making assistance. We retrospectively analyzed the breast cancer patients recorded in the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2016. Multivariable logistic regression analyses were used to identify risk factors for bone metastases in breast cancer, whereas Cox proportional hazards regression analyses were used to identify prognostic factors for breast cancer with bone metastasis (BCBM). Based on the identified risk and prognostic factors, we developed diagnostic and prognostic models that incorporate six machine learning classifiers. We then used the area under the receiver operating characteristic (ROC) curve (AUC), learning curve, precision curve, calibration plot, and decision curve analysis to evaluate performance of the machine learning models. Univariable and multivariable logistic regression analyses showed that bone metastases were significantly associated with age, race, sex, grade, T stage, N stage, surgery, radiotherapy, chemotherapy, tumor size, brain metastasis, liver metastasis, lung metastasis, breast subtype, and PR. Univariate and multivariate Cox regression analyses revealed that age, race, marital status, grade, surgery, radiotherapy, chemotherapy, brain metastasis, liver metastasis, lung metastasis, breast subtype, ER, and PR were closely associated with the prognosis of BCBM. Among the six machine learning models, the XGBoost algorithm predicted the most accurate results (Diagnostic model AUC = 0.98; Prognostic model AUC = 0.88). According to the Shapley additive explanations (SHAP), the most critical feature of the diagnostic model was surgery, followed by N stage. Interestingly, surgery was also the most critical feature of prognostic model, followed by liver metastasis. Based on the XGBoost algorithm, we could effectively predict the diagnosis and survival of bone metastasis in breast cancer and provide targeted references for the treatment of BCBM patients.Keywords
All Related Versions
Funding Information
- the Key Research and Development Program of Zhejiang Province (2021C03078)
This publication has 45 references indexed in Scilit:
- Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their MetastasesClinical Cancer Research, 2017
- Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manualCA: A Cancer Journal for Clinicians, 2017
- Emerging therapeutic targets in metastatic progression: A focus on breast cancerPharmacology & Therapeutics, 2016
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trialThe Lancet Oncology, 2015
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Breast cancer metastasis to the bone: mechanisms of bone lossBreast Cancer Research, 2010
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosisEuropean Journal of Surgical Oncology, 2009
- Zoledronic acid and skeletal complications in patients with solid tumors and bone metastasesCancer, 2008
- Clinical Features of Metastatic Bone Disease and Risk of Skeletal MorbidityClinical Cancer Research, 2006
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001